LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma
Abstract Previous research found that LIM domain kinase 2 (LIMK2) expression correlated with a poor prognosis in many cancers. However,…
